Skip to Main Content
An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

DRE and LUTS

Principal Investigator

Name
Jonathan Shoag

Institution
NA

Position Title
Resident physician

Email
jes9171@nyp.org

About this CDAS Project

Study
PLCO (Learn more about this study)

Project ID
PLCO-177

Initial CDAS Request Approval
Nov 6, 2015

Title
DRE and LUTS

Summary
Though the digital rectal exam (DRE) is a key component of prostate cancer screening, its utility in the workup of lower urinary tract symptoms is poorly understood. Nocturia is among the most bothersome lower urinary tract symptoms, and its multifactorial etiology requires broad clinical evaluation. Using data from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial, this study aims to assess the accuracy and reliability of DRE in estimating prostate size and to correlate these findings to the presence of nocturia.

Aims

1. To assess the accuracy and reliability of DRE in estimating prostate size
2. To correlate these findings to the presence of nocturia.

Related Publications